liraglutide
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
37 FDA-registered drug labelers
A-S Medication Solutions
Aurobindo Pharma Limited
Bachem Americas, Inc.
Biocon Limited
Biocon Pharma Inc.
Chengdu Shengnuo Biopharm Co. Ltd.
Cipla USA Inc.
DARMERICA, LLC
Dr. Reddy's Laboratories Limited
ETERNAL WEALTH(CHINA)LIMITED
FRESENIUS KABI IPSUM SRL
Fujian Genohope Biotech Ltd.
Hikma Pharmaceuticals USA Inc.
Hubei JXBio Pharmaceutical Co., Ltd
Hybio Pharmaceutical Co., Ltd.
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
Lupin Pharmaceuticals, Inc.
Meitheal Pharmaceuticals Inc.
MSN Life Sciences Private Limited
Nanjing Chengong Pharmaceutical Co., Ltd.
Nanjing Hanxin Pharmaceutical Technology Co., Ltd.
Nanjing Xingyin Pharmaceutical Group Co.,Ltd
NOMIDA LLC
NorthStar Rx LLC
Novo Nordisk
Novo Nordisk A/S
Orbicular Pharmaceutical Technologies Private Limited
Polypeptide Laboratories Inc
Qingdao Biopeptek Co., Ltd.
ScinoPharm Taiwan Ltd.
Shanghai Ambiopharm, Inc
Sinopep-Allsino Biopharmaceutical Co., Ltd.
SUN PHARMACEUTICAL INDUSTRIES, INC.
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals, Inc.
Tonghua Dongbao Pharmaceutical Co., Ltd
Zhejiang Peptites Biotech Co., Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 4 drug and cosmetic product listings (FDA).
- •Liraglutide
- •Xultophy 100/3.6
- •Victoza
- •Saxenda
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Liraglutide Injection
07/18/2023Available
current
Liraglutide Injection
07/18/2023Limited Availability
Chemical Identity
CAS204656-20-2
PubChem CID16134956
DTXSIDDTXSID60174433
FormulaC172H265N43O51
Mol. Weight3751 g/mol
SMILESCCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O
Data Sources
161349562026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/liraglutide/cids/JSON
Archive: data/sources/pubchem_name/liraglutide.json
CAS 204656-20-22026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 204656-20-22026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json